DiviDrip · AKTX

AKTX — Akari Therapeutics, Plc

AKTX is Akari Therapeutics, Plc (Healthcare) — a non-dividend-paying stock. Trading at $11.47. Market cap: $22M. Capital Quality Rank: 9/100 — Systemic risk.

Stock snapshot

Price$11.47
Market cap$22M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)9 / 100 · Systemic risk
ROIC (TTM)-59.0%
Shareholder buyback yield-30.00%
Altman Z-score zoneDistress

About AKTX

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer. Its payload, PH1, targets RNA splicing by modulating the spliceosome, a complex machinery in the cell that converts pre-RNA into spliced RNA for translation into vital proteins for cell survival and growth. Its product pipeline is AKTX-101, which targets the Trop2 receptor on cancer cells and, with a proprietary linker, enables it to deliver its novel PH1 payload directly into the tumor with minimal off-target effects. and AKTX-102, an ADC candidate targeting CEACAM5 (Carcinoembryonic Antigen-related Cell Adhesion Molecule-5), a well-validated tumor antigen expressed across multiple solid tumors.

Listed2012Employees5HQTampa, FLSectorHealthcareWebsiteakaritx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside AKTX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is AKTX's current stock price?

AKTX (Akari Therapeutics, Plc) is currently trading at $11.47.

Does AKTX pay a dividend?

AKTX (Akari Therapeutics, Plc) does not currently pay a regular dividend.

What is AKTX's Capital Quality Rank?

AKTX has a Capital Quality Rank of 9/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track AKTX in DiviDrip

Add AKTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow